Cellular and molecular mechanisms in allograft arteriosclerosis.
Häyry
P
P
Transplantation Laboratory, University of Helsinki, Finland.
Mennander
A
A
Yilmaz
S
S
Ustinov
J
J
Räisänen
A
A
Lautenschlager
I
I
Lemström
K
K
Bruggeman
C A
CA
Paavonen
T
T
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology* / Q000517:prevention & control; D016207:Cytokines / Q000502:physiology; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000517:prevention & control; D006084:Graft Rejection / Q000209:etiology* / Q000517:prevention & control; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D011183:Postoperative Complications / Q000209:etiology* / Q000517:prevention & control
D016207:Cytokines; D006133:Growth Substances